Drug Database
Back to search

Switzerland· 61270002

Micardis Amlo 40/5 mg, Tabletten

A telmisartan and amlodipine product containing telmisartanum, amlodipinum, registered in Switzerland by Boehringer Ingelheim (Schweiz) GmbH and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C09DB04

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedMicardis Amlo 40/5 mg, TablettenATCC09DB04REGISTER NO.61270002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about telmisartanum, amlodipinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Telmisartan and amlodipine is registered in 11 of 19 countries.

Countries holding a registration under ATC C09DB04 (telmisartan and amlodipine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search telmisartan and amlodipine products by name

Telmisartan and amlodipine · ATC C09DB04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
telmisartanum, amlodipinum
Manufacturer
Boehringer Ingelheim (Schweiz) GmbH
Country
Switzerland (CH)
ATC code
C09DB04
ATC class
Telmisartan and amlodipine
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680612700029
    98 Stk
    CHF 69.75

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

46 interactions on record for telmisartan and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check telmisartan and amlodipine against other medicinesHow interaction checks work

Telmisartan and amlodipine · interactions on record

46 records

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Telmisartan and amlodipine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All telmisartan and amlodipine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Telmisartan/Amlodipin Krka
  • Bulgaria · Актелсар Дуо, Равентон
  • Czechia · Tamloset, Telassmo
  • Germany · Actelsar Duo, Telmisartan/Amlodipin 089pharm
  • Estonia · Mixor, Teldipin
  • Spain · Telmisartán/Amlodipino Krka, Telmisartán/Amlodipino Teva
  • France · Telmisartan/Amlodipine Arrow
  • Greece · Cardynsta
  • Hungary · Arettan, Cotanydon
  • Iceland · Twynsta
  • Liechtenstein · Twynsta
  • Lithuania · Raventon
  • Latvia · Mixor, Raventon
  • Norway · Twynsta
  • Poland · Telam, Teldipin
  • Portugal · Amlodipina + Telmisartan Generis, Amlodipina + Telmisartan Krka
  • Romania · Telassmo
  • Slovenia · Telassmo
  • Slovakia · Mixor, Teldipin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7decc179-babb-4f40-8263-d79983764caa
GET /v1/drugs/7decc179-babb-4f40-8263-d79983764caa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "telmisartanum 40 mg + amlodipinum 5 mg",
  "valid_from": "2011-02-01",
  "limitations": null,
  "galenic_form": "Tabl 40/5mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2011-02-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about telmisartan and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console